COMPANY PRODUCT TYPE THERAPEUTIC AREA INDICATION PHASE STUDIES LOCATION PRODUCT
Ability Pharmaceuticals ABTL0815 Biodrugs/ Drugs Cancer Solid Tumors 1NRP ABTL0815
Therapeutic area: Cancer
Ability Pharmaceuticals ABTL0812 Biodrugs/ Drugs Cancer Lung, Endometrial and Pancreatic Cancer 4PhII ABTL0812
Therapeutic area: Cancer
Ability Pharmaceuticals ABTL1014 Biodrugs/ Drugs Blood and Lymphatic systems
Cancer
Leukaemia and Lymphomas 2RP ABTL1014
Therapeutic area: Blood and Lymphatic systems
Cancer
Almirall KX2-391 Biodrugs/ Drugs Dermatology Actinic keratosis 5PhIII KX2-391
Therapeutic area: Dermatology
Almirall ADP12734 Biodrugs/ Drugs Autoimmune & Inflammation
Dermatology
Psoriasis 2RP ADP12734
Therapeutic area: Autoimmune & Inflammation
Dermatology
Almirall ADP12778 Biodrugs/ Drugs Autoimmune & Inflammation
Dermatology
Atopic dermatitis 2RP ADP12778
Therapeutic area: Autoimmune & Inflammation
Dermatology
Almirall Tildrakizumab Biodrugs/ Drugs Autoimmune & Inflammation
Dermatology
Psoriasis 6Reg. Tildrakizumab
Therapeutic area: Autoimmune & Inflammation
Dermatology
Almirall P3058 Biodrugs/ Drugs Dermatology Onychomycosis 5PhIII P3058
Therapeutic area: Dermatology
Almirall P3074 Biodrugs/ Drugs Dermatology Androgenetic Alopecia 5PhIII P3074
Therapeutic area: Dermatology
Almirall PAT001 Biodrugs/ Drugs Dermatology
Genetic Diseases and Dysmorphic syndromes
Ichthyosis 4PhII PAT001
Therapeutic area: Dermatology
Genetic Diseases and Dysmorphic syndromes
Almirall ADP13612 Biodrugs/ Drugs Dermatology Rosacea 2RP ADP13612
Therapeutic area: Dermatology
Aptatargets ApTOLL-03 Biodrugs/ Drugs Autoimmune & Inflammation Multiple Sclerosis 1NRP ApTOLL-03
Therapeutic area: Autoimmune & Inflammation
Aptatargets ApTOLL-01 Biodrugs/ Drugs Cardiovascular and circulatory systems
Central Nervous System
Acute ischemic stroke Acute coronary syndrome 2RP ApTOLL-01
Therapeutic area: Cardiovascular and circulatory systems
Central Nervous System
APTUS Biotech ApTLR-4FT Biodrugs/ Drugs Central Nervous System Acute stroke 1NRP ApTLR-4FT
Therapeutic area: Central Nervous System
Araclon Biotech ABvac40 Biodrugs/ Drugs Central Nervous System Alzheimer's Disease 4PhII ABvac40
Therapeutic area: Central Nervous System
Archivel Farma RUTI Vaccines Cancer Bladder cancer. 3PhI RUTI
Therapeutic area: Cancer
Archivel Farma RUTI® Vaccines Infections Active tuberculosis - Latent Tuberculosis 4PhII Europe and South Africa RUTI®
Therapeutic area: Infections
ASCIL Biopharm ONYMED for nail diseases Biodrugs/ Drugs Dermatology ONYMED is an innovative long acting technology platform designed to provide a safer and more efficient way to treat or prevent nail disorders and diseases. ONYMED allows to dramatically reduce the dose and the frequency of treatment. For licensing. 3PhI ONYMED for nail diseases
Therapeutic area: Dermatology
ASCIL Biopharm APOC new treatment for NET Biodrugs/ Drugs Cancer APOC is a new drug product containing octreotide, the best in class somatostatin analogue (SSA) and the cornerstone of therapy for patients with Neuroendocrine Tumors (NETs) and acromegaly. ASCIL is selecting partner(s) for pivotal phase III studies. 4PhII APOC new treatment for NET
Therapeutic area: Cancer
ATRYS HEALTH NILO1 Biodrugs/ Drugs Cancer
Central Nervous System
Brain tumor and brain lesions 1NRP Spain NILO1
Therapeutic area: Cancer
Central Nervous System
BIOFABRI MTBVAC Vaccines Infections
Respiratory and Pulmonary system
Vaccine against Tuberculosis. MTBVAC is a live, attenuated vaccine, manufactured by Biofabri from a genetically modified strain from a human isolate. MTBVAC is in Phase 2A clinical trials in newborns and adults in South Africa. 4PhII MTBVAC
Therapeutic area: Infections
Respiratory and Pulmonary system
Bioibérica Duartron Biodrugs/ Drugs Musculoskeletal Disorders Alleviation of mild to moderate osteoarthritis of the knee 6Reg. Duartron
Therapeutic area: Musculoskeletal Disorders
Bioibérica Hialsorb intra-articular injection Biodrugs/ Drugs Musculoskeletal Disorders Indicated for treatment of degenerative or mechanical joint diseases 6Reg. Spain Hialsorb intra-articular injection
Therapeutic area: Musculoskeletal Disorders
Bioibérica Condrosan Biodrugs/ Drugs Musculoskeletal Disorders Symptomatic treatment of osteoarthritis 6Reg. Spain Condrosan
Therapeutic area: Musculoskeletal Disorders
Bioibérica Droglican Biodrugs/ Drugs Musculoskeletal Disorders Symptomatic treatment of knee osteoarthritis 6Reg. Spain Droglican
Therapeutic area: Musculoskeletal Disorders
Bioibérica BIS014 Biodrugs/ Drugs Analgesia & Pain
Central Nervous System
Neuropathic pain 2RP Europe BIS014
Therapeutic area: Analgesia & Pain
Central Nervous System
Bioibérica Cartisorb Biodrugs/ Drugs Musculoskeletal Disorders Symptomatic treatment of osteoarthritis 6Reg. Spain Cartisorb
Therapeutic area: Musculoskeletal Disorders
Bionanoplus Psorio-Plus spray and gel Biodrugs/ Drugs Dermatology Help improving and soothing the manifestations of hyperkeratinized skins 2RP Psorio-Plus spray and gel
Therapeutic area: Dermatology
Bionanoplus CAX-LAST (Carbenoxolone mucoadhesive paste) Biodrugs/ Drugs Others Carbenoxolone paste for treatment of recurrent aphtous ulcers (RAS) (local mucosal delivery). 1NRP CAX-LAST (Carbenoxolone mucoadhesive paste)
Therapeutic area: Others
Bionanoplus Amorolfine Transungual Formulation Biodrugs/ Drugs Infections Onychomycosis 1NRP Amorolfine Transungual Formulation
Therapeutic area: Infections
Bionanoplus Propylene Glycol Free Minoxidil Topical Formulation Biodrugs/ Drugs Dermatology Hair Loss 6Reg. Europe Propylene Glycol Free Minoxidil Topical Formulation
Therapeutic area: Dermatology
Bionanoplus Ciclopirox Transungual Formulation Biodrugs/ Drugs Infections Onychomycosis 1NRP Ciclopirox Transungual Formulation
Therapeutic area: Infections
Bionanoplus Cyclosporine Topical Ophthalmic Formulation Biodrugs/ Drugs Ophthalmology and optometry Dry eye Syndrome 1NRP Cyclosporine Topical Ophthalmic Formulation
Therapeutic area: Ophthalmology and optometry
Bionanoplus MUCOZOL-LAST (Miconazole mucoadhesive paste) Biodrugs/ Drugs Others Anti-fungal Miconazole paste for buccal and oral delivery. 1NRP MUCOZOL-LAST (Miconazole mucoadhesive paste)
Therapeutic area: Others
Bioncotech Therapeutics BO-112 Biodrugs/ Drugs Cancer Solid tumors 3PhI BO-112
Therapeutic area: Cancer
Bionure BN201 Biodrugs/ Drugs Central Nervous System
Ophthalmology and optometry
Acute Optic Neuritis, Neuromyelitis Optica, Multiple Sclerosis 3PhI BN201
Therapeutic area: Central Nervous System
Ophthalmology and optometry
DIOMUNE SL IV1303 Biodrugs/ Drugs Autoimmune & Inflammation
Cardiovascular and circulatory systems
Genetic Diseases and Dysmorphic syndromes
Infections
Sepsis treatment, Stroke, Rare diseases (CDH), Leishmania, ZIKV 2RP IV1303
Therapeutic area: Autoimmune & Inflammation
Cardiovascular and circulatory systems
Genetic Diseases and Dysmorphic syndromes
Infections
ENTRECHEM EC-8042 iv for Ewing sarcoma Biodrugs/ Drugs Cancer Solid tumours 2RP EC-8042 iv for Ewing sarcoma
Therapeutic area: Cancer
ENTRECHEM EC-8042 iv for liposarcoma Biodrugs/ Drugs Cancer liposarcoma myxoide 2RP EC-8042 iv for liposarcoma
Therapeutic area: Cancer
ENTRECHEM EC-70124 po for AML Biodrugs/ Drugs Cancer Acute myeloid leukemia 2RP EC-70124 po for AML
Therapeutic area: Cancer
ENTRECHEM EC-8042 iv for Triple negative breast cancer Biodrugs/ Drugs Cancer Triple negative breast cancer 2RP EC-8042 iv for Triple negative breast cancer
Therapeutic area: Cancer
ENTRECHEM Brasilicardin analogs Biodrugs/ Drugs Autoimmune & Inflammation Immunosupression 1NRP Brasilicardin analogs
Therapeutic area: Autoimmune & Inflammation
ENTRECHEM EC-70124 po for TNBC Biodrugs/ Drugs Cancer Triple negative breast cancer 2RP EC-70124 po for TNBC
Therapeutic area: Cancer
ENTRECHEM EC-70124 po for prostate cancer Biodrugs/ Drugs Cancer Castration resistant prostate cancer 2RP EC-70124 po for prostate cancer
Therapeutic area: Cancer
ESTEVE EGT-301 Gene / Cell Therapy Genetic Diseases and Dysmorphic syndromes Hunter syndrome: Lysosomal storage disease 1NRP EGT-301
Therapeutic area: Genetic Diseases and Dysmorphic syndromes
ESTEVE EGT-201 Gene / Cell Therapy Genetic Diseases and Dysmorphic syndromes Sanfilippo B syndrome: Lisosomal storage rare disease 1NRP EGT-201
Therapeutic area: Genetic Diseases and Dysmorphic syndromes
ESTEVE EGT-101 Gene / Cell Therapy Genetic Diseases and Dysmorphic syndromes Sanfilippo A syndrome:Lysosomal storage rare disease 2RP EGT-101
Therapeutic area: Genetic Diseases and Dysmorphic syndromes
ESTEVE E-52862 Biodrugs/ Drugs Analgesia & Pain Neuropathic Pain 4PhII E-52862
Therapeutic area: Analgesia & Pain
ESTEVE E-58425 Biodrugs/ Drugs Analgesia & Pain Acute and chronic, moderate to severe pain 5PhIII E-58425
Therapeutic area: Analgesia & Pain
ESTEVE MUMO1 Biodrugs/ Drugs Analgesia & Pain Acute and chronic, moderate to severe pain 2RP MUMO1
Therapeutic area: Analgesia & Pain
FECYT Pylori Biodrugs/ Drugs Infections H. pylori 2RP Pylori
Therapeutic area: Infections
FECYT p300 Biodrugs/ Drugs Cancer Cancer 2RP p300
Therapeutic area: Cancer
FECYT p38 Biodrugs/ Drugs Analgesia & Pain
Central Nervous System
Neuropathic Pain 2RP p38
Therapeutic area: Analgesia & Pain
Central Nervous System
FERRER Ozenoxacin Biodrugs/ Drugs Dermatology
Infections
Dermal infections 6Reg. Ozenoxacin
Therapeutic area: Dermatology
Infections
FERRER FAB-120 Biodrugs/ Drugs Ophthalmology and optometry Diabetic Retinopathy 2RP FAB-120
Therapeutic area: Ophthalmology and optometry
FERRER FAB-112 Gene / Cell Therapy Ophthalmology and optometry Corneal Diseases 2RP FAB-112
Therapeutic area: Ophthalmology and optometry
FERRER Lorediplon Biodrugs/ Drugs Central Nervous System Sleep disorders 4PhII Lorediplon
Therapeutic area: Central Nervous System
FERRER FAB-117 Gene / Cell Therapy Central Nervous System Spinal Cord Injury 3PhI FAB-117
Therapeutic area: Central Nervous System
FIBROSTATIN FS-SME-T12 Biodrugs/ Drugs Cancer
Metabolic / Endocrinology
Respiratory and Pulmonary system
Advanced solid tumors Type 2 diabetes Idiopathic pulmonary fibrosis 1NRP FS-SME-T12
Therapeutic area: Cancer
Metabolic / Endocrinology
Respiratory and Pulmonary system
FIBROSTATIN FS-MAB-hN26 Biodrugs/ Drugs Cancer
Metabolic / Endocrinology
Respiratory and Pulmonary system
Advanced solid tumors Type 2 diabetes Idiopathic pulmonary fibrosis 1NRP FS-MAB-hN26
Therapeutic area: Cancer
Metabolic / Endocrinology
Respiratory and Pulmonary system
FUND. PROGRESO Y SALUD Allogeneic Adipose Mesenchymal stem cells / Allodepleted Bone Marrow Progenitors Biodrugs/ Drugs Autoimmune & Inflammation
Blood and Lymphatic systems
Chronic Graft versus Host Disease, Haematological Malignancies 4PhII Allogeneic Adipose Mesenchymal stem cells / Allodepleted Bone Marrow Progenitors
Therapeutic area: Autoimmune & Inflammation
Blood and Lymphatic systems
FUND. PROGRESO Y SALUD FIBAO-116 Biodrugs/ Drugs Analgesia & Pain Fibromyalgia 3PhI FIBAO-116
Therapeutic area: Analgesia & Pain
FUND. PROGRESO Y SALUD FIMABIS-77 Biodrugs/ Drugs Central Nervous System Hydroxytyrosol ethers 2RP FIMABIS-77
Therapeutic area: Central Nervous System
FUND. PROGRESO Y SALUD Engineered Corneas Gene / Cell Therapy Ophthalmology and optometry Corneal ulcers 4PhII Engineered Corneas
Therapeutic area: Ophthalmology and optometry
FUND. PROGRESO Y SALUD FIMABIS-13001 Biodrugs/ Drugs Metabolic / Endocrinology Treatment and/or Prevention of Non-alcoholic fatty liver disease (NAFLD) 2RP FIMABIS-13001
Therapeutic area: Metabolic / Endocrinology
FUND. PROGRESO Y SALUD Autologous Bone Marrow Mononuclear cells Gene / Cell Therapy Cardiovascular and circulatory systems
Metabolic / Endocrinology
Critical Limb Ischemia in diabetic patients 3PhI Autologous Bone Marrow Mononuclear cells
Therapeutic area: Cardiovascular and circulatory systems
Metabolic / Endocrinology
FUND. PROGRESO Y SALUD Autologous Bone Marrow progenitors, Adipose and Bone Marrow Mesenchymal stem cells Gene / Cell Therapy Autoimmune & Inflammation
Central Nervous System
Stroke, Multiple Sclerosis and ALS 4PhII Autologous Bone Marrow progenitors, Adipose and Bone Marrow Mesenchymal stem cells
Therapeutic area: Autoimmune & Inflammation
Central Nervous System
FUND. PROGRESO Y SALUD CABIMER-14001 Condon plasma factors for skin regeneration Gene / Cell Therapy Autoimmune & Inflammation
Dermatology
Dermatitis 1NRP CABIMER-14001 Condon plasma factors for skin regeneration
Therapeutic area: Autoimmune & Inflammation
Dermatology
FUND. PROGRESO Y SALUD FIMABIS-13007 Biodrugs/ Drugs Cardiovascular and circulatory systems
Metabolic / Endocrinology
Treatment and/or prevention of metabolic and cardiovascular diseases 2RP FIMABIS-13007
Therapeutic area: Cardiovascular and circulatory systems
Metabolic / Endocrinology
FUND. PROGRESO Y SALUD Autologous Bone Marrow Mononuclear cells and Adipose Mesenchymal stem cells Gene / Cell Therapy Digestive System Extended Liver resection, Faecal Incontinence 4PhII Autologous Bone Marrow Mononuclear cells and Adipose Mesenchymal stem cells
Therapeutic area: Digestive System
FUND. PROGRESO Y SALUD CABIMER-11 New target gene and delivery systems for the Treatment of Retinitis Pigmentosa Gene / Cell Therapy Ophthalmology and optometry Retinitis pigmentosa 1NRP CABIMER-11 New target gene and delivery systems for the Treatment of Retinitis Pigmentosa
Therapeutic area: Ophthalmology and optometry
FUND. PROGRESO Y SALUD FISEVI-14012 Biodrugs/ Drugs Infections Multirresistant infections 2RP FISEVI-14012
Therapeutic area: Infections
FUND. PROGRESO Y SALUD FISEVI-13007 Gene / Cell Therapy Cancer Hepatocarcinoma 2RP FISEVI-13007
Therapeutic area: Cancer
FUND. PROGRESO Y SALUD Autologous Bone Marrow Mononuclear cells Gene / Cell Therapy Cardiovascular and circulatory systems
Metabolic / Endocrinology
Acute Myocardial Infarction/Dilated Myocardiopathy/Chronic Ischemic Cardiopathy/Critical Limb Ischemia in diabetic & non patients 4PhII Autologous Bone Marrow Mononuclear cells
Therapeutic area: Cardiovascular and circulatory systems
Metabolic / Endocrinology
FUND. PROGRESO Y SALUD CABIMER-13003 Vaccines Central Nervous System Parkinson 1NRP CABIMER-13003
Therapeutic area: Central Nervous System
FUND. PROGRESO Y SALUD FIBICO-14003 Gene / Cell Therapy Musculoskeletal Disorders Musculoskeletal disorders 1NRP FIBICO-14003
Therapeutic area: Musculoskeletal Disorders
FUND. PROGRESO Y SALUD FRM-5 Gene / Cell Therapy Others Transplant 2RP FRM-5
Therapeutic area: Others
FUND. PROGRESO Y SALUD FIMABIS-14003 Biodrugs/ Drugs Dermatology
Infections
Treatment of mucocutaneous herpes infections 4PhII FIMABIS-14003
Therapeutic area: Dermatology
Infections
FUND. PROGRESO Y SALUD FIBICO-14002 Biodrugs/ Drugs Cancer Metastatic processes and resistant cancers 1NRP FIBICO-14002
Therapeutic area: Cancer
FUND. PROGRESO Y SALUD FISEVI-13020 Biodrugs/ Drugs Central Nervous System Alzheimer's disease 2RP FISEVI-13020
Therapeutic area: Central Nervous System
FUND. PROGRESO Y SALUD FISEVI 141 Biodrugs/ Drugs Infections Sepsis, Acute lung injury 2RP FISEVI 141
Therapeutic area: Infections
FUND. PROGRESO Y SALUD FISEVI-13002 Biodrugs/ Drugs Cancer Multiple myeloma 2RP FISEVI-13002
Therapeutic area: Cancer
FUND. PROGRESO Y SALUD FISEVI-121 Gene / Cell Therapy Autoimmune & Inflammation Transplant 2RP FISEVI-121
Therapeutic area: Autoimmune & Inflammation
FUND. PROGRESO Y SALUD FIBAO-13007 Gene / Cell Therapy Cancer Cancer cells 2RP FIBAO-13007
Therapeutic area: Cancer
FUND. PROGRESO Y SALUD FIBAO-91 Melatonine Solution Biodrugs/ Drugs Infections Sepsis 4PhII FIBAO-91 Melatonine Solution
Therapeutic area: Infections
FUND. PROGRESO Y SALUD FIBAO-13014 Combination of Ketamine and Meperidine Biodrugs/ Drugs Autoimmune & Inflammation Mucositis 3PhI FIBAO-13014 Combination of Ketamine and Meperidine
Therapeutic area: Autoimmune & Inflammation
FUND. PROGRESO Y SALUD FIMABIS-99 Biodrugs/ Drugs Metabolic / Endocrinology Nanoemulsions for the treatment of obesity 2RP FIMABIS-99
Therapeutic area: Metabolic / Endocrinology
FUNDACIÓN JIMÉNEZ DÍAZ (Instituto de Investigación Sanitaria) New generation of peptides Biodrugs/ Drugs Autoimmune & Inflammation
Blood and Lymphatic systems
Cardiovascular and circulatory systems
Kidney and Genitourinary system
Metabolic / Endocrinology
Ophthalmology and optometry
Chronic complications of Diabetes / Choric kidney disease 2RP New generation of peptides
Therapeutic area: Autoimmune & Inflammation
Blood and Lymphatic systems
Cardiovascular and circulatory systems
Kidney and Genitourinary system
Metabolic / Endocrinology
Ophthalmology and optometry
FUNDACIÓN JIMÉNEZ DÍAZ (Instituto de Investigación Sanitaria) Peptide derived from a natural compound Biodrugs/ Drugs Autoimmune & Inflammation
Metabolic / Endocrinology
Osteoporosis treatment 1NRP Peptide derived from a natural compound
Therapeutic area: Autoimmune & Inflammation
Metabolic / Endocrinology
FUNDACIÓN JIMÉNEZ DÍAZ (Instituto de Investigación Sanitaria) Advanced cell therapies Gene / Cell Therapy Ophthalmology and optometry Eye rare diseases 4PhII Spain / Europe Advanced cell therapies
Therapeutic area: Ophthalmology and optometry
FUNDACIÓN JIMÉNEZ DÍAZ (Instituto de Investigación Sanitaria) Mutli-target siRNA approach Gene / Cell Therapy Autoimmune & Inflammation
Kidney and Genitourinary system
Chronic Kidney Disease (CKD)/ Akute Kidney Injury (AKI) 2RP Mutli-target siRNA approach
Therapeutic area: Autoimmune & Inflammation
Kidney and Genitourinary system
FUNDACIÓN JIMÉNEZ DÍAZ (Instituto de Investigación Sanitaria) Advanced cell therapies Gene / Cell Therapy Blood and Lymphatic systems
Cancer
Oncology / Haematological disorders 3PhI Spain / US Advanced cell therapies
Therapeutic area: Blood and Lymphatic systems
Cancer
Fundacion MEDINA MDN-018 Biodrugs/ Drugs Infections Fungal Infections 1NRP MDN-018
Therapeutic area: Infections
Fundacion MEDINA MDN-0109, MDN-110, MDN-111, MDN- 112 Biodrugs/ Drugs Infections Malaria 1NRP MDN-0109, MDN-110, MDN-111, MDN- 112
Therapeutic area: Infections
Fundacion MEDINA MDN-057/MDN-058/MDN-059 Biodrugs/ Drugs Infections Gram negative infections 1NRP MDN-057/MDN-058/MDN-059
Therapeutic area: Infections
Fundacion MEDINA MDN-0090 Biodrugs/ Drugs Cancer Pancreatic Cancer 1NRP MDN-0090
Therapeutic area: Cancer
Fundacion MEDINA MDN-0145; MDN-0146 Biodrugs/ Drugs Central Nervous System Parkinson 1NRP MDN-0145; MDN-0146
Therapeutic area: Central Nervous System
Fundacion MEDINA MDN-005 Biodrugs/ Drugs Central Nervous System
Musculoskeletal Disorders
Amyotrophic lateral sclerosis (ALS) 1NRP MDN-005
Therapeutic area: Central Nervous System
Musculoskeletal Disorders
Fundacion MEDINA MDN-0147; MDN-0148 & MDN-0149 Biodrugs/ Drugs Cancer Melanoma 1NRP MDN-0147; MDN-0148 & MDN-0149
Therapeutic area: Cancer
Fundacion MEDINA MDN-088 Biodrugs/ Drugs Cancer Breast, Colon & Lung Cancer 1NRP MDN-088
Therapeutic area: Cancer
Genmedica Therapeutics GMC-252 Biodrugs/ Drugs Metabolic / Endocrinology Type 2 Diabetes 3PhI Europe GMC-252
Therapeutic area: Metabolic / Endocrinology
GP-PHARM Triptorelina Depot 1-3 Biodrugs/ Drugs Cancer Prostate Cancer 3PhI Triptorelina Depot 1-3
Therapeutic area: Cancer
GP-PHARM Lutrate Depot 45 mg Biodrugs/ Drugs Cancer Prostate Cancer 3PhI Worldwide Lutrate Depot 45 mg
Therapeutic area: Cancer
GP-PHARM Pegylated Liposomes for Oncology Biodrugs/ Drugs Cancer Advanced Ovarian Cancer, Advanced Breast Cancer 3PhI Worldwide Pegylated Liposomes for Oncology
Therapeutic area: Cancer
GP-PHARM Octeotride LAR Biodrugs/ Drugs Metabolic / Endocrinology Acromegaly 4PhII Worldwide Octeotride LAR
Therapeutic area: Metabolic / Endocrinology
GP-PHARM depot form. Biodrugs/ Drugs Cancer Several 3PhI depot form.
Therapeutic area: Cancer
GP-PHARM TERIPERATIDE Biodrugs/ Drugs Musculoskeletal Disorders Osteoporosis 3PhI TERIPERATIDE
Therapeutic area: Musculoskeletal Disorders
GP-PHARM Lutrate Depot 22,5 mg Biodrugs/ Drugs Cancer Prostate Cancer 6Reg. Lutrate Depot 22,5 mg
Therapeutic area: Cancer
GP-PHARM Desmopresina Solution Biodrugs/ Drugs Kidney and Genitourinary system Nocturnal Enuresis 6Reg. Desmopresina Solution
Therapeutic area: Kidney and Genitourinary system
Histocell HR016 Biodrugs/ Drugs Respiratory and Pulmonary system Acute Lung Injury 2RP HR016
Therapeutic area: Respiratory and Pulmonary system
Histocell HC016 Biodrugs/ Drugs Central Nervous System Acute Spinal Cord Injury 4PhII HC016
Therapeutic area: Central Nervous System
Histocell HR004 Biodrugs/ Drugs Musculoskeletal Disorders Bone Regeneration 4PhII HR004
Therapeutic area: Musculoskeletal Disorders
IIS La Fe Mutant of candida albicans and use in therapy against candidiasis Biodrugs/ Drugs Infections Mutant of candida albicans and use in therapy against candidiasis 1NRP Mutant of candida albicans and use in therapy against candidiasis
Therapeutic area: Infections
InKemia IUCT group IUCT-DS-0347 Biodrugs/ Drugs Cancer Breast cancer 1NRP IUCT-DS-0347
Therapeutic area: Cancer
InKemia IUCT group IUCT-DS-0263 Biodrugs/ Drugs Cancer Breast cancer 1NRP IUCT-DS-0263
Therapeutic area: Cancer
InKemia IUCT group IUCT-DS-0086 Biodrugs/ Drugs Cancer Breast cancer 1NRP IUCT-DS-0086
Therapeutic area: Cancer
InKemia IUCT group DIS-COM-COAG Biodrugs/ Drugs Cardiovascular and circulatory systems Anticoagulants 1NRP DIS-COM-COAG
Therapeutic area: Cardiovascular and circulatory systems
InKemia IUCT group DIS-BIO-EPS Biodrugs/ Drugs Analgesia & Pain
Autoimmune & Inflammation
Osteoarthritis 1NRP DIS-BIO-EPS
Therapeutic area: Analgesia & Pain
Autoimmune & Inflammation
InKemia IUCT group DIS-BIO-VIR Biodrugs/ Drugs Infections Antivirals 1NRP DIS-BIO-VIR
Therapeutic area: Infections
InKemia IUCT group DIS-BIO-CAN Biodrugs/ Drugs Cancer Antineoplastic 1NRP DIS-BIO-CAN
Therapeutic area: Cancer
InKemia IUCT group IUCT-DS-0423 Biodrugs/ Drugs Cancer Prostate cancer 1NRP IUCT-DS-0423
Therapeutic area: Cancer
InKemia IUCT group DIS-COM-TROP Biodrugs/ Drugs Central Nervous System Migraine 1NRP DIS-COM-TROP
Therapeutic area: Central Nervous System
InKemia IUCT group IUCT-DS-0347 Biodrugs/ Drugs Cancer Prostate cancer 1NRP Europe IUCT-DS-0347
Therapeutic area: Cancer
InKemia IUCT group DIS-COM-BRA Biodrugs/ Drugs Respiratory and Pulmonary system Asthma 1NRP DIS-COM-BRA
Therapeutic area: Respiratory and Pulmonary system
InKemia IUCT group IUCT-DS-0263 Biodrugs/ Drugs Cancer Prostate cancer 1NRP Europe IUCT-DS-0263
Therapeutic area: Cancer
InKemia IUCT group DIS-COM-BRA Biodrugs/ Drugs Analgesia & Pain
Autoimmune & Inflammation
Inflammation 1NRP DIS-COM-BRA
Therapeutic area: Analgesia & Pain
Autoimmune & Inflammation
InKemia IUCT group IUCT-DS-0423 Biodrugs/ Drugs Cancer Breast cancer 1NRP IUCT-DS-0423
Therapeutic area: Cancer
Institut Quimic de Sarrià (IQS) Chondro-implant Gene / Cell Therapy Cardiovascular and circulatory systems Bioactive implant for myocardial regeneration, ventricular support and elliptical shape restoration. Acute Cartilage Injure 1NRP Chondro-implant
Therapeutic area: Cardiovascular and circulatory systems
Institut Quimic de Sarrià (IQS) Cardio-implant Gene / Cell Therapy Cardiovascular and circulatory systems PCL (Polycaprolactone), SAP (self-assembling peptide) bioactive and biomimetic scaffolds for cartilage regeneration. Heart infarct 1NRP Cardio-implant
Therapeutic area: Cardiovascular and circulatory systems
Iproteos IPR-166 Biodrugs/ Drugs Central Nervous System Cognitive Impairment Associated with Schizophrenia (CIAS) 2RP IPR-166
Therapeutic area: Central Nervous System
Iproteos IPR-179 Biodrugs/ Drugs Central Nervous System Epilepsy 1NRP IPR-179
Therapeutic area: Central Nervous System
IRYCIS New compound for the treatment of isquemical stroke Biodrugs/ Drugs Central Nervous System Isquemic stroke 1NRP Spain New compound for the treatment of isquemical stroke
Therapeutic area: Central Nervous System
Leukos Biotech LK-01 Biodrugs/ Drugs Blood and Lymphatic systems
Cancer
AML 3PhI LK-01
Therapeutic area: Blood and Lymphatic systems
Cancer
Lipopharma Therapeutics LP30171 Biodrugs/ Drugs Cancer
Metabolic / Endocrinology
Metabolic Diseases, cancer 1NRP LP30171
Therapeutic area: Cancer
Metabolic / Endocrinology
Lipopharma Therapeutics LP226A1 Biodrugs/ Drugs Central Nervous System Alzheimer's Disease 2RP LP226A1
Therapeutic area: Central Nervous System
Lipopharma Therapeutics LP205A1 Biodrugs/ Drugs Cardiovascular and circulatory systems
Central Nervous System
Metabolic / Endocrinology
Cardiovascular and Metabolic Diseases, CNS, 1NRP LP205A1
Therapeutic area: Cardiovascular and circulatory systems
Central Nervous System
Metabolic / Endocrinology
Lipopharma Therapeutics LPA181 Biodrugs/ Drugs Central Nervous System Spinal Cord Injury, Pain. Global rigths outlicensed to a third party biotech company 2RP LPA181
Therapeutic area: Central Nervous System
Lipopharma Therapeutics LP204A1 Biodrugs/ Drugs Autoimmune & Inflammation
Cardiovascular and circulatory systems
Inflammation, Cardiovascular 1NRP LP204A1
Therapeutic area: Autoimmune & Inflammation
Cardiovascular and circulatory systems
Lipopharma Therapeutics LP561A1 Biodrugs/ Drugs Cancer Glioma and other solid tumours 4PhII LP561A1
Therapeutic area: Cancer
Minoryx MIN-102 Biodrugs/ Drugs Central Nervous System
Metabolic / Endocrinology
X-linked Adrenoleukodystrophy 4PhII MIN-102
Therapeutic area: Central Nervous System
Metabolic / Endocrinology
NATAC Retriacyl Biodrugs/ Drugs Ophthalmology and optometry Retinitis Pigmentosa 5PhIII Europe Retriacyl
Therapeutic area: Ophthalmology and optometry
nLife Therapeutics, S.L. NLF-PD-1233 Biodrugs/ Drugs Central Nervous System Parkinson Disease 2RP Europe and USA NLF-PD-1233
Therapeutic area: Central Nervous System
Oryzon ORY-3001 Biodrugs/ Drugs Others Non-oncological disease 2RP ORY-3001
Therapeutic area: Others
Oryzon ORY-2001 Biodrugs/ Drugs Central Nervous System Alzheimer's disease, Multiple Sclerosis, Huntington's disease, other dementias, 4PhII ORY-2001
Therapeutic area: Central Nervous System
Oryzon OG-new series in KDM Biodrugs/ Drugs Cancer
Others
Solid cancers, Oncohaematology 1NRP OG-new series in KDM
Therapeutic area: Cancer
Others
Oryzon ORY-1001 Biodrugs/ Drugs Blood and Lymphatic systems
Cancer
Acute Myeloid Leukaemia, SCLC, other solid tumors; other oncohaematology indications 4PhII ORY-1001
Therapeutic area: Blood and Lymphatic systems
Cancer
PaloBiofarma PBF-509 Biodrugs/ Drugs Cancer
Central Nervous System
Lung Cancer 4PhII Spain PBF-509
Therapeutic area: Cancer
Central Nervous System
PaloBiofarma PBF680 Biodrugs/ Drugs Respiratory and Pulmonary system Asthma 4PhII Spain PBF680
Therapeutic area: Respiratory and Pulmonary system
PaloBiofarma PBF-1129 Biodrugs/ Drugs Cancer Lung Cancer 3PhI Spain PBF-1129
Therapeutic area: Cancer
PaloBiofarma PBF-677 Biodrugs/ Drugs Digestive System Colitis 4PhII Spain PBF-677
Therapeutic area: Digestive System
PaloBiofarma PBF-999 Biodrugs/ Drugs Cancer Solid Tumors 3PhI Spain PBF-999
Therapeutic area: Cancer
PharmaMar LURBINECTEDIN (PM1183) Biodrugs/ Drugs Cancer BRCA2 Pancreatic 4PhII NA LURBINECTEDIN (PM1183)
Therapeutic area: Cancer
PharmaMar PM184 Biodrugs/ Drugs Cancer Colorectal Cancer 4PhII EU & NA PM184
Therapeutic area: Cancer
PharmaMar TRABECTEDIN + PLD Biodrugs/ Drugs Cancer Ovarian Cancer. 5PhIII Europe TRABECTEDIN + PLD
Therapeutic area: Cancer
PharmaMar PM184 Biodrugs/ Drugs Cancer Solid tumors 3PhI EU & NA PM184
Therapeutic area: Cancer
PharmaMar TRABECTEDIN Biodrugs/ Drugs Cancer Retroperitoneal L-Sarcoma 4PhII Italy TRABECTEDIN
Therapeutic area: Cancer
PharmaMar PM184 + TRABECTEDIN Biodrugs/ Drugs Cancer Soft tissue Sarcoma 3PhI EU PM184 + TRABECTEDIN
Therapeutic area: Cancer
PharmaMar PM14 Biodrugs/ Drugs Cancer Solid tumors 3PhI EU PM14
Therapeutic area: Cancer
PharmaMar TRABECTEDIN + Radiotherapy Biodrugs/ Drugs Cancer Sarcoma 4PhII Europe TRABECTEDIN + Radiotherapy
Therapeutic area: Cancer
PharmaMar TRABECTEDIN + PLD Biodrugs/ Drugs Cancer Ovarian cancer (Japan) 3PhI Japan TRABECTEDIN + PLD
Therapeutic area: Cancer
PharmaMar LURBINECTEDIN (PM1183) Biodrugs/ Drugs Cancer Platinum-Resistant ovarian cancer. 5PhIII Europe and NA LURBINECTEDIN (PM1183)
Therapeutic area: Cancer
PharmaMar LURBINECTEDIN (PM1183) Biodrugs/ Drugs Cancer Solid tumors 3PhI Japan LURBINECTEDIN (PM1183)
Therapeutic area: Cancer
PharmaMar LURBINECTEDIN (PM1183) + DOXORUBICIN Biodrugs/ Drugs Cancer Small Cell lung cancer 5PhIII EU , LA & LATAM LURBINECTEDIN (PM1183) + DOXORUBICIN
Therapeutic area: Cancer
PharmaMar LURBINECTEDIN (PM1183) Biodrugs/ Drugs Cancer Ewing Sarcoma 4PhII EU & NA LURBINECTEDIN (PM1183)
Therapeutic area: Cancer
PharmaMar LURBINECTEDIN (PM1183) Biodrugs/ Drugs Cancer Small Cell Lung Cancer 4PhII EU & NA LURBINECTEDIN (PM1183)
Therapeutic area: Cancer
PharmaMar LURBINECTEDIN (PM1183) Biodrugs/ Drugs Cancer Solid tumors 4PhII EU & NA LURBINECTEDIN (PM1183)
Therapeutic area: Cancer
PharmaMar LURBINECTEDIN (PM1183) Biodrugs/ Drugs Cancer Endometrial cancer 4PhII EU & NA LURBINECTEDIN (PM1183)
Therapeutic area: Cancer
PRAXIS EPIPROT Biodrugs/ Drugs Dermatology Diabetic Foot 5PhIII EPIPROT
Therapeutic area: Dermatology
PRAXIS NANOPLATFORMM Biodrugs/ Drugs Infections NANOFORMULATION OF DRUGS FOR RESISTANT INFECTIONS 1NRP NANOPLATFORMM
Therapeutic area: Infections
PRAXIS BERENICE Biodrugs/ Drugs Genetic Diseases and Dysmorphic syndromes Chagas 5PhIII BERENICE
Therapeutic area: Genetic Diseases and Dysmorphic syndromes
PRAXIS NANOENZHIMES Biodrugs/ Drugs Genetic Diseases and Dysmorphic syndromes SANFILIPPO/FABRY 1NRP NANOENZHIMES
Therapeutic area: Genetic Diseases and Dysmorphic syndromes
PRAXIS NNE Biodrugs/ Drugs Dermatology Diabetic Foot 1NRP NNE
Therapeutic area: Dermatology
PRAXIS TAT-CF Biodrugs/ Drugs Genetic Diseases and Dysmorphic syndromes CYSTIC FIBROSIS 1NRP TAT-CF
Therapeutic area: Genetic Diseases and Dysmorphic syndromes
PRAXIS NANOCANTHER Biodrugs/ Drugs Cancer THERAPY SYSTEMS FOR PANCREATIC CANCER 1NRP NANOCANTHER
Therapeutic area: Cancer
PRAXIS Nanoantibiotics Gene / Cell Therapy Respiratory and Pulmonary system Resistent Infections (Cystic Fibrosis) 1NRP Nanoantibiotics
Therapeutic area: Respiratory and Pulmonary system
PRAXIS CLINGLIO Biodrugs/ Drugs Cancer Glioma 4PhII CLINGLIO
Therapeutic area: Cancer
PRAXIS ANTIAGE Biodrugs/ Drugs Dermatology ANTIAGING DRUGS AND NUTRACEUTICS 1NRP ANTIAGE
Therapeutic area: Dermatology
PRAXIS ATEROLESS Biodrugs/ Drugs Dermatology ANTIAGING COSMETIC AND NUTRACEUTICS 1NRP ATEROLESS
Therapeutic area: Dermatology
PRAXIS TERFIQEC Gene / Cell Therapy Genetic Diseases and Dysmorphic syndromes Cystic Fibrosis 2RP TERFIQEC
Therapeutic area: Genetic Diseases and Dysmorphic syndromes
PRAXIS IGRALZHEIMER Biodrugs/ Drugs Central Nervous System ALZHEIMER 1NRP IGRALZHEIMER
Therapeutic area: Central Nervous System
PRAXIS PROHEAL Biodrugs/ Drugs Dermatology Bioactive wound dressings (Diabetic / vascular) 1NRP PROHEAL
Therapeutic area: Dermatology
PRAXIS TERARMET Biodrugs/ Drugs Others SANFILIPPO 1NRP TERARMET
Therapeutic area: Others
REIG JOFRE Topical solution Biodrugs/ Drugs Dermatology Skin infections 5PhIII Spain, Mexico Topical solution
Therapeutic area: Dermatology
Sanifit SNF472 Biodrugs/ Drugs Cardiovascular and circulatory systems
Metabolic / Endocrinology
Calciphylaxis (dialysis) 4PhII SNF472
Therapeutic area: Cardiovascular and circulatory systems
Metabolic / Endocrinology
Sanifit SNF472 Biodrugs/ Drugs Cardiovascular and circulatory systems
Metabolic / Endocrinology
Cardiovascular disease (dialysis) 4PhII SNF472
Therapeutic area: Cardiovascular and circulatory systems
Metabolic / Endocrinology
SOM Biotech SOM3355 Biodrugs/ Drugs Central Nervous System
Genetic Diseases and Dysmorphic syndromes
Huntington's disease, Tourette syndrome and Tardive Dyskinesia 4PhII SOM3355
Therapeutic area: Central Nervous System
Genetic Diseases and Dysmorphic syndromes
SOM Biotech SOM1202 Biodrugs/ Drugs Central Nervous System
Genetic Diseases and Dysmorphic syndromes
Adrenomyeloneuropathy 1NRP SOM1202
Therapeutic area: Central Nervous System
Genetic Diseases and Dysmorphic syndromes
SOM Biotech SOM1201 Biodrugs/ Drugs Central Nervous System
Genetic Diseases and Dysmorphic syndromes
Adrenoleukodystrophy 4PhII SOM1201
Therapeutic area: Central Nervous System
Genetic Diseases and Dysmorphic syndromes
SOM Biotech SOM2201 Biodrugs/ Drugs Central Nervous System
Genetic Diseases and Dysmorphic syndromes
Musculoskeletal Disorders
Duchenne Muscular Dystrophy 1NRP SOM2201
Therapeutic area: Central Nervous System
Genetic Diseases and Dysmorphic syndromes
Musculoskeletal Disorders
SPHERIUM BIOMED SP15016 Biodrugs/ Drugs Cardiovascular and circulatory systems
Kidney and Genitourinary system
Prevention of Acute Kidney Injury in Angioplasty patients receiving high dose contrast agent 3PhI SP15016
Therapeutic area: Cardiovascular and circulatory systems
Kidney and Genitourinary system
SPHERIUM BIOMED SP13004 Biodrugs/ Drugs Cancer
Dermatology
Digestive System
Prevention and treatment of radiochemotherapy-induced mucositis in head and neck cancer 4PhII SP13004
Therapeutic area: Cancer
Dermatology
Digestive System
SPHERIUM BIOMED SP12006 Biodrugs/ Drugs Analgesia & Pain
Musculoskeletal Disorders
Treatment of mild to moderate muscular pain (related to sportive practice DOMS and Temporomandibular Joint Disorder) 4PhII SP12006
Therapeutic area: Analgesia & Pain
Musculoskeletal Disorders
SPHERIUM BIOMED SP14019 Biodrugs/ Drugs Dermatology topical spray of cyclosporine to treat Atopic Dermatitis & Psoriasis 4PhII SP14019
Therapeutic area: Dermatology
SPHERIUM BIOMED SP1440 Biodrugs/ Drugs Central Nervous System Small Mollecule. Schizophrenia and cognitive improvement 2RP SP1440
Therapeutic area: Central Nervous System
Sylentis siRNA / SYL1801 Biodrugs/ Drugs Ophthalmology and optometry Retina 2RP siRNA / SYL1801
Therapeutic area: Ophthalmology and optometry
Sylentis siRNA / SYL116011 Biodrugs/ Drugs Ophthalmology and optometry Ocular Allergy 2RP siRNA / SYL116011
Therapeutic area: Ophthalmology and optometry
Sylentis Tivanisirán / SYL1001 Biodrugs/ Drugs Ophthalmology and optometry Dry Eye Syndrome 5PhIII Tivanisirán / SYL1001
Therapeutic area: Ophthalmology and optometry
Sylentis Bamosiran / SYL040012 Biodrugs/ Drugs Ophthalmology and optometry Ocular Hypertension, Glaucoma 4PhII Bamosiran / SYL040012
Therapeutic area: Ophthalmology and optometry
TERACLON IDF V-32-R Biodrugs/ Drugs Ophthalmology and optometry Glaucoma 2RP V-32-R
Therapeutic area: Ophthalmology and optometry
TERACLON IDF V32R Biodrugs/ Drugs Ophthalmology and optometry Diabetic Retinopathy 2RP V32R
Therapeutic area: Ophthalmology and optometry
TERACLON IDF T1649 Biodrugs/ Drugs Autoimmune & Inflammation
Dermatology
Psoriasis 1NRP T1649
Therapeutic area: Autoimmune & Inflammation
Dermatology
Thrombotargets TT-112 Biodrugs/ Drugs Blood and Lymphatic systems Antifibrinolysis 1NRP TT-112
Therapeutic area: Blood and Lymphatic systems
Thrombotargets TT-173 Biodrugs/ Drugs Blood and Lymphatic systems Haemorrhage 5PhIII TT-173
Therapeutic area: Blood and Lymphatic systems
VCN Biosciences VCN-11 Gene / Cell Therapy Cancer Solid Tumors 2RP VCN-11
Therapeutic area: Cancer
VCN Biosciences VCN-02 Gene / Cell Therapy Cancer Solid Tumors 1NRP VCN-02
Therapeutic area: Cancer
VCN Biosciences VCN-01 Gene / Cell Therapy Cancer Head & Neck Cancer 3PhI VCN-01
Therapeutic area: Cancer
VCN Biosciences VCN-01 Gene / Cell Therapy Cancer Pancreatic cancer 3PhI VCN-01
Therapeutic area: Cancer
VCN Biosciences VCN-01 Gene / Cell Therapy Cancer Retinoblastoma 3PhI VCN-01
Therapeutic area: Cancer
VENTER PHARMA LacTEST 2,7 g Biodrugs/ Drugs Digestive System Evaluation of hypolactasia 5PhIII LacTEST 2,7 g
Therapeutic area: Digestive System
VENTER PHARMA LacTEST 0,45 g Biodrugs/ Drugs Digestive System Evaluation of hypolactasia 6Reg. LacTEST 0,45 g
Therapeutic area: Digestive System
Vivia Biotech Vivia 009 Biodrugs/ Drugs Blood and Lymphatic systems
Central Nervous System
Non Hodgkin Lymphoma, CNS 2RP Europe Vivia 009
Therapeutic area: Blood and Lymphatic systems
Central Nervous System
Vivia Biotech Vivia 011 Biodrugs/ Drugs Metabolic / Endocrinology Obesity, Diabetes 1NRP Vivia 011
Therapeutic area: Metabolic / Endocrinology
Vytrus Biotech PhyPsor Biodrugs/ Drugs Autoimmune & Inflammation
Dermatology
Psoriasis 1NRP PhyPsor
Therapeutic area: Autoimmune & Inflammation
Dermatology